What You Should Know: - MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform. - Dexcom, a global leader in real-time continuous glucose monitoring, serves over 537 million individuals worldwide living with diabetes. Through wearable devices synced with smartphones, patients' glucose data becomes accessible to clinicians via MD Revolution's care management platform,
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Report Reveals Digital Diabetes Management Tools Fail to Deliver Benefits, Increase Costs
What You Should Know: - Digital diabetes management tools are failing to deliver meaningful health benefits to patients, according to a new evaluation by the Peterson Health Technology Institute (PHTI). - The report casts doubt on the effectiveness of widely used digital diabetes management tools. Despite billions in investment, the study finds these tools offer minimal health benefits and actually increase healthcare spending. Millions Rely on Tools, But Evidence Shows Little
Read More
Know Labs Unveils KnowU: Wearable Non-Invasive CGM Poised to Revolutionize Glucose Monitoring
What You Should Know: - Know Labs (NYSE American: KNW), a leading innovator in non-invasive medical diagnostic technology, today announced the unveiling of its KnowU™, a wearable, non-invasive continuous glucose monitor (CGM). - With over 270 patents issued, pending, and in process, Know Labs has established a solid foundation for its technology, creating a competitive advantage in the non-invasive CGM landscape. Wearable, Non-invasive Continuous Glucose Monitor Just eight months
Read More
Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management
What You Should Know: - Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs. - Medicare has significantly expanded access to the Eversense E3 CGM System, the longest-lasting continuous glucose monitor available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal-only patients, by the first three
Read More
The High Price of Living with Diabetes in 2024: A Breakdown of Costs
What You Should Know: - The average person with diabetes could spend between $3,300 and $4,600 a year on out-of-pocket costs, including prescription medications, provider visits, over-the-counter supplies, and lost wages, according to a recent GoodRx report. - The report, The True Cost of Diabetes takes into account medications, visits with healthcare providers, and blood sugar level monitoring, as well as costs for emergency room visits, hospital stays, and chronic complications for those
Read More
Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US
What You Should Know: - Tandem Diabetes Care and Abbott have joined forces to bring the first automated insulin delivery (AID) system in the US compatible with Abbott's latest FreeStyle Libre 2 Plus sensor. - The integration brings the benefits of advanced closed-loop technology to millions of Americans living with diabetes, helping them achieve better blood sugar control and manage their condition with greater ease. Seamless Integration for Precise Control: The t:slim X2 insulin
Read More
How Hospitals Can Overcome the Challenges of Diabetes Management
The modern-day hospital is grappling with an alarming trend. According to a new global study, the number of people with diabetes is growing at a troubling rate and is expected to double by 2050. This is generating a national conversation among health system leaders on inpatient glycemic management strategies, and whether their facilities are doing enough. Hospitals and health systems have long understood the need to reduce preventable hypoglycemia, yet despite a renewed sense of urgency, many of
Read More
Withings Launches Body Pro 2 for Early Diabetes Detection
What You Should Know: - Withings Health Solutions has launched Body Pro 2, a revolutionary cellular-connected smart scale that is designed to improve the way patients with diabetes are cared for. - Body Pro 2 is a cellular-connected smart scale that can be used to capture advanced health metrics such as weight and body composition. Diabetic Foot Ulcers Assessment The first module of Body Pro 2 is prescription-only and focuses on improving care for patients with diabetes, addressing
Read More
Prescribing Trends Surge: Wegovy & Ozempic Gain Popularity, Survey Shows
What You Should Know: - Prescriptions for the popular weight loss drug Wegovy showed a six-fold increase between December 2022 and June 2023, according to a recent analysis of prescribing trends by DrFirst. - Prescriptions for Ozempic, the lower-dose version for treating diabetes, increased by 65% during the same period among doctors on the DrFirst prescribing network. - DrFirst's network includes over 350,000 prescribers across the U.S., including 260,000 doctors, who use their
Read More
DaVita, Google Cloud to Develop Customized Clinical OS to Transform Kidney Care
What You Should Know: - DaVita Inc. and Google Cloud are teaming up to create a new clinical operating system that sets a foundation for streamlined kidney care for more than 200,000 DaVita patients. - Built on Google Cloud infrastructure and utilizing AI and analytics tools co-developed by the two companies, DaVita's Center Without Walls (CWOW) is now live across the organization's 2,700+ dialysis centers nationwide. - With the deployment, DaVita has moved from a
Read More
